genetic drivers of lung cancer by number of mutations | oncotarget
Published 2 years ago • 45 plays • Length 1:18Download video MP4
Download video MP3
Similar videos
-
15:17
oncotarget: retaining nanomolar potency in lung cancer with therapy-refractory mutations
-
0:52
oncotarget | characterization of kk-lc-1 in lung cancer
-
3:44
what is a driver mutation?
-
4:09
impact of driver mutations in nsclc
-
0:46
oncotarget: lp-184 retains potency in refractory lung cancer
-
1:01
novel keap1/nrf2 target gene regulating ferroptosis and radioresistance in lung cancers | oncotarget
-
1:17
updates on met targeted therapy for exon 14 mutations in lung cancer | oncotarget
-
2:35
is my lung cancer mutation genetic? - 2022 program: testing and early diagnosis
-
5:29
the role of driver mutations in nsclc treatment - 2022 program: lcvl
-
6:22
gene mutations in nsclc
-
1:23
targeting tumour drivers and resistance
-
6:55
oncotarget: a chance for targeting cancer stem cells in human non-small cell lung cancer?
-
14:06
who’s driving treatment? two co-occurring driver mutations in primary lung adenocarcinoma
-
2:11
genetic investigation: pathogenic variants in saudi patients with familial cancer | oncotarget
-
7:07
oncotarget | findings offer new clues for targeting drug resistant colon cancers
-
3:09
identification of driver mutations in transbronchial needle aspirates of suspicious lung nodules
-
2:40
value of chemotherapy post immunotherapy in stage iv non-small cell lung cancer (nsclc) | oncotarget
-
26:33
targeted therapy of lung cancer with or without driver mutations